The FDA wants to pull its approval of a drug. It’s not so easy.
Summary
The regulator says Tavneos was approved on the basis of manipulated study data. Should patients still have access to it?
Description from Ars Technica.
Who is covering this
-
The FDA wants to pull its approval of a drug. It’s not so easy.
The regulator says Tavneos was approved on the basis of manipulated study data. Should patients still have access to it?
Related stories
Actor Ajay Devgn moves High Court against FDA notice over Vimal Elaichi ads
7 sourcesvia The HinduTruth score 731
FDA scientists opposed Trump administration’s move to ease peptide access
4 sourcesvia The GuardianTruth score 66
Blood pressure medication recalled nationwide. See the affected drugs
4 sourcesvia USA TODAYTruth score 67
Patanjali ghee among Rs 9 crore food stock seized in Maharashtra FDA crackdown
3 sourcesvia India TodayTruth score 54
Trump administration says biggest changes coming to infant formula in nearly 30 years
2 sourcesvia ABC News (US)Truth score 533
FDA issues alert about Northfield-based Medline beds tied to fire-related deaths and injuries
3 sourcesvia Chicago Sun-TimesTruth score 59
Comments
Comments need JavaScript.